Skip to main content
APURES CO., LTD. logo

APURES CO., LTD. — Investor Relations & Filings

Ticker · 149300 ISIN · KR7149300006 KO Professional, scientific and technical activities
Filings indexed 196 across all filing types
Latest filing 2026-03-06 Regulatory Filings
Country KR South Korea
Listing KO 149300

About APURES CO., LTD.

https://www.apures.com/

APURES CO., LTD. is a biotechnology company specializing in research and development solutions centered on its proprietary "MICROPIG" platform. This internationally registered minipig model, which is anatomically and physiologically similar to humans, serves as a foundation for the company's diverse offerings. APURES develops and supplies standard and transgenic MICROPIG models, along with a portfolio of derived bio-resources including organs, tissues, and standardized primary cells for cell-based assays. The company provides comprehensive non-clinical contract research organization (CRO) services, offering integrated in-vitro and in-vivo testing solutions tailored for new drug development. Additionally, APURES is advancing into therapeutic innovation, developing bio-materials for xenotransplantation and tissue engineering, and pursuing the development of its own pipeline of gene therapies.

Recent filings

Filing Released Lang Actions
불성실공시법인지정 (공시불이행)
Regulatory Filings Classification · 95% confidence The document is a formal regulatory notice regarding the designation of a company as an 'unfaithful disclosure corporation' (불성실공시법인) due to a failure to disclose litigation in a timely manner. This is a regulatory announcement concerning compliance and legal/regulatory status, which fits the definition of a Regulatory Filing (RNS) as it does not fall into specific categories like M&A, dividends, or financial reports.
2026-03-06 Korean
불성실공시법인지정예고 (공시불이행)
Regulatory Filings Classification · 95% confidence The document is a formal notice from a regulatory body (exchange) regarding the designation of a company as an 'unfaithful disclosure corporation' (불성실공시법인) due to a failure to disclose litigation. This is a regulatory announcement concerning compliance and legal status, which does not fit into specific categories like financial reports or shareholder meetings. Therefore, it is classified as a general regulatory filing.
2026-02-19 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by a major shareholder (AmWest Funding Korea) and special related parties in the company 'Apures'. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2026-01-29 Korean
[기재정정]최대주주변경
Board/Management Information Classification · 95% confidence The document is a regulatory filing from a Korean company (Apures) regarding a change in the largest shareholder (최대주주 변경). It details the correction of a previous filing, the specific changes in shareholding percentages, and the reasons for the change (collateral execution). This type of disclosure is a standard regulatory announcement regarding corporate ownership structure, which falls under the 'Regulatory Filings' category as it does not fit into specific categories like 'Major Shareholding Notification' (which usually refers to external investors reporting their own holdings) or 'Director's Dealing'.
2026-01-28 Korean
소송등의제기ㆍ신청(일정금액이상의청구)
Legal Proceedings Report Classification · 100% confidence The document is a formal regulatory disclosure regarding a legal proceeding (a payment order/lawsuit) filed against the company 'Apures'. It details the plaintiff, the claim amount, the court, and the company's planned response. This fits the definition of a Legal Proceedings Report (LTR) as it concerns significant lawsuits or regulatory actions involving the company.
2026-01-23 Korean
주주명부폐쇄기간또는기준일설정
Notice of Dividend Amount Classification · 95% confidence The document is a short regulatory announcement regarding the setting of a record date for an upcoming Annual General Meeting (AGM). It specifies the record date (2026-01-30) and the purpose (holding the 25th Annual General Meeting). Since it is a regulatory announcement regarding meeting logistics rather than the meeting materials themselves or a proxy statement, it falls under the general regulatory filing category.
2026-01-15 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.